OcrelizumabPsychiatric syndrome: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1776卷 / 1期

关键词：

D O I：

10.1007/s40278-019-70502-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：344 / 344

相关论文

共 50 条

[31] CarbamazepineDRESS syndrome: 2 case reports
Reactions Weekly, 2014, 1514 (1) : 15 - 15
[32] AtomoxetineActivation syndrome: 2 case reports
Reactions Weekly, 2024, 2037 (1) : 69 - 69
[33] AllopurinolHypersensitivity syndrome: 2 case reports
Reactions Weekly, 2017, 1648 (1) : 25 - 25
[34] VemurafenibDRESS syndrome: 2 case reports
Reactions Weekly, 2017, 1671 (1) : 375 - 375
[35] AzathioprineMyelodysplastic syndrome: 2 case reports
Reactions Weekly, 2013, 1459 (1) : 9 - 9
[36] PhenytoinDRESS syndrome: 2 case reports
Reactions Weekly, 2012, 1384 (1) : 45 - 45
[37] VancomycinDRESS syndrome: 2 case reports
Reactions Weekly, 2012, 1400 (1) : 39 - 39
[38] SiliconASIA syndrome: 2 case reports
Reactions Weekly, 2022, 1906 (1) : 348 - 348
[39] AntineoplasticsMyelodysplastic syndrome: 2 case reports
Reactions Weekly, 2011, 1378 (1) : 8 - 8
[40] RisperidoneRabbit syndrome: 2 case reports
Reactions Weekly, 2013, 1434 (1) : 56 - 56

← 1 2 3 4 5 →